{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:54:08Z","timestamp":1784314448589,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Photochem Photobiol Sci"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1039\/c5pp00438a","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T09:32:49Z","timestamp":1463131969000},"page":"812-821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy"],"prefix":"10.1007","volume":"15","author":[{"given":"Katar\u00edna","family":"Gyur\u00e1szov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarom\u00edr","family":"Mike\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Halaburkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rastislav","family":"Jend\u017eelovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fedoro\u010dko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"issue":"5","key":"1506011_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, 2011, 1445, 646\u2013674.","journal-title":"Cell"},{"issue":"12","key":"1506011_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","volume":"90","author":"T J Dougherty","year":"1998","unstructured":"T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst., 1998, 9012, 889\u2013905.","journal-title":"J. Natl. Cancer Inst."},{"issue":"14\u201315","key":"1506011_CR3","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.phytochem.2011.06.011","volume":"72","author":"S Onoue","year":"2011","unstructured":"S. Onoue, Y. Seto, M. Ochi, R. Inoue, H. Ito, T. Hatano and S. Yamada, In vitro photochemical and phototoxicological characterization of major constituents in St. John\u2019s Wort (Hypericum perforatum) extracts, Phytochemistry, 2011, 7214\u201315, 1814\u20131820.","journal-title":"Phytochemistry"},{"issue":"2","key":"1506011_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.pdpdt.2015.04.003","volume":"12","author":"C Bernal","year":"2015","unstructured":"C. Bernal, A. O. Ribeiro, G. P. Andrade and J. R. Perussi, Photodynamic efficiency of hypericin compared with chlorin and hematoporphyrin derivatives in HEp-2 and Vero epithelial cell lines, Photodiagn. Photodyn. Ther., 2015, 122, 176\u2013185.","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"2","key":"1506011_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/ijms11020562","volume":"11","author":"A Karioti","year":"2010","unstructured":"A. Karioti and A. R. Bilia, Hypericins as potential leads for new therapeutics, Int. J. Mol. Sci., 2010, 112, 562\u2013594.","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"1506011_CR6","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.2174\/092986711795843272","volume":"18","author":"A Casas","year":"2011","unstructured":"A. Casas, G. Di Venosa, T. Hasan and B. Al, Mechanisms of resistance to photodynamic therapy, Curr. Med. Chem., 2011, 1816, 2486\u20132515.","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"1506011_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc2293","volume":"8","author":"D C Altieri","year":"2008","unstructured":"D. C. Altieri, Survivin, cancer networks and pathway-directed drug discovery, Nat. Rev. Cancer, 2008, 81, 61\u201370.","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"1506011_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ctrv.2013.02.002","volume":"39","author":"M S Coumar","year":"2013","unstructured":"M. S. Coumar, F. Y. Tsai, J. R. Kanwar, S. Sarvagalla and C. H. Cheung, Treat cancers by targeting survivin: just a dream or future reality?, Cancer Treat. Rev., 2013, 397, 802\u2013811.","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"1506011_CR9","first-page":"179","volume":"3","author":"Q Cheng","year":"2012","unstructured":"Q. Cheng, X. Ling, A. Haller, T. Nakahara, K. Yamanaka, A. Kita, H. Koutoku, M. Takeuchi, M. G. Brattain and F. Li, Suppression of survivin promoter activity by YM155 involves disruption of Sp1-DNA interaction in the survivin core promoter, Int. J. Biochem. Mol. Biol., 2012, 32, 179\u2013197.","journal-title":"Int. J. Biochem. Mol. Biol."},{"issue":"3","key":"1506011_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1349-7006.2010.01834.x","volume":"102","author":"T Nakahara","year":"2011","unstructured":"T. Nakahara, A. Kita, K. Yamanaka, M. Mori, N. Amino, M. Takeuchi, F. Tominaga, I. Kinoyama, A. Matsuhisa, M. Kudou and M. Sasamata, Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models, Cancer Sci., 2011, 1023, 614\u2013621.","journal-title":"Cancer Sci."},{"issue":"1","key":"1506011_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.bjc.6605713","volume":"103","author":"T Iwasa","year":"2010","unstructured":"T. Iwasa, I. Okamoto, K. Takezawa, K. Yamanaka, T. Nakahara, A. Kita, H. Koutoku, M. Sasamata, E. Hatashita, Y. Yamada, K. Kuwata, M. Fukuoka and K. Nakagawa, Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs, Br. J. Cancer, 2010, 1031, 36\u201342.","journal-title":"Br. J. Cancer"},{"issue":"11","key":"1506011_CR12","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1182\/blood-2012-05-427773","volume":"121","author":"J Chen","year":"2013","unstructured":"J. Chen, C. A. Pise-Masison, J. H. Shih, J. C. Morris, J. E. Janik, K. C. Conlon, A. Keating and T. A. Waldmann, Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia, Blood, 2013, 12111, 2029\u20132037.","journal-title":"Blood"},{"issue":"2","key":"1506011_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ijc.28993","volume":"136","author":"M Pennati","year":"2015","unstructured":"M. Pennati, S. Sbarra, M. De Cesare, A. Lopergolo, S. L. Locatelli, E. Campi, M. G. Daidone, C. Carlo-Stella, A. M. Gianni and N. Zaffaroni, YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation, Int. J. Cancer, 2015, 1362, 299\u2013309.","journal-title":"Int. J. Cancer"},{"key":"1506011_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T C Chou","year":"1984","unstructured":"T. C. Chou and P. Talalay, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv. Enzyme Regul., 1984, 22, 27\u201355.","journal-title":"Adv. Enzyme Regul."},{"issue":"7","key":"1506011_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1039\/B700350A","volume":"6","author":"J Mikes","year":"2007","unstructured":"J. Mikes, J. Kleban, V. Sackova, V. Horvath, E. Jamborova, A. Vaculova, A. Kozubik, J. Hofmanova and P. Fedorocko, Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin, Photochem. Photobiol. Sci., 2007, 67, 758\u2013766.","journal-title":"Photochem. Photobiol. Sci."},{"issue":"PtB","key":"1506011_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jconrel.2015.09.014","volume":"220","author":"Y Oh","year":"2015","unstructured":"Y. Oh, M. Swierczewska, T. H. Kim, S. M. Lim, H. N. Eom, J. H. Park, D. H. Na, K. Kim, K. C. Lee, M. G. Pomper and S. Lee, Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors, J. Controlled Release, 2015, 220Pt B, 671\u2013681.","journal-title":"J. Controlled Release"},{"issue":"2","key":"1506011_CR17","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5487\/TR.2015.31.2.151","volume":"31","author":"A Y Kim","year":"2015","unstructured":"A. Y. Kim, J. H. Kwak, N. K. Je, Y. H. Lee and Y. S. Jung, Epithelial-mesenchymal Transition is Associated with Acquired Resistance to 5-Fluorocuracil in HT-29 Colon Cancer Cells, Toxicol. Res., 2015, 312, 151\u2013156.","journal-title":"Toxicol. Res."},{"issue":"3","key":"1506011_CR18","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.3892\/mmr.2015.3890","volume":"12","author":"G Yang","year":"2015","unstructured":"G. Yang, O. Jiang, D. Ling, X. Jiang, P. Yuan, G. Zeng, J. Zhu, J. Tian, Y. Weng and D. Wu, MicroRNA-522 reverses drug resistance of doxorubicin-induced HT29 colon cancer cell by targeting ABCB5, Mol. Med. Rep., 2015, 123, 3930\u20133936.","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"1506011_CR19","doi-asserted-by":"publisher","first-page":"e0123830","DOI":"10.1371\/journal.pone.0123830","volume":"10","author":"A Gines","year":"2015","unstructured":"A. Gines, S. Bystrup, V. Ruiz de Porras, C. Guardia, E. Musulen, A. Martinez-Cardus, J. L. Manzano, L. Layos, A. Abad, E. Martinez-Balibrea, PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines, PLoS One, 2015, 105, e0123830.","journal-title":"PLoS One"},{"issue":"10","key":"1506011_CR20","doi-asserted-by":"publisher","first-page":"10099","DOI":"10.1021\/acsnano.5b03677","volume":"9","author":"M Zhao","year":"2015","unstructured":"M. Zhao, H. Li, X. Bu, C. Lei, Q. Fang and Z. Hu, Quantitative Proteomic Analysis of Cellular Resistance to the Nanoparticle Abraxane, ACS Nano, 2015, 910, 10099\u201310112.","journal-title":"ACS Nano"},{"issue":"4","key":"1506011_CR21","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3892\/ijo.2015.3144","volume":"47","author":"H Li","year":"2015","unstructured":"H. Li, P. Zhang, X. Sun, Y. Sun, C. Shi, H. Liu and X. Liu, MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells, Int. J. Oncol., 2015, 474, 1379\u20131392.","journal-title":"Int. J. Oncol."},{"key":"1506011_CR22","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1038\/emm.2015.24","volume":"47","author":"T Kwon","year":"2015","unstructured":"T. Kwon, J. K. Rho, J. C. Lee, Y. H. Park, H. J. Shin, S. Cho, Y. K. Kang, B. Y. Kim, D. Y. Yoon and D. Y. Yu, An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib, Exp. Mol. Med., 2015, 47, e165.","journal-title":"Exp. Mol. Med."},{"issue":"24","key":"1506011_CR23","doi-asserted-by":"publisher","first-page":"20513","DOI":"10.18632\/oncotarget.4109","volume":"6","author":"W H Chiu","year":"2015","unstructured":"W. H. Chiu, W. C. Su, C. L. Li, C. L. Chen and C. F. Lin, An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells, Oncotarget, 2015, 624, 20513\u201320524.","journal-title":"Oncotarget"},{"issue":"4","key":"1506011_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.pdpdt.2013.04.003","volume":"10","author":"L Mikesova","year":"2013","unstructured":"L. Mikesova, J. Mikes, J. Koval, K. Gyuraszova, L. Culka, J. Vargova, B. Valekova and P. Fedorocko, Conjunction of glutathione level, NAD(P)H\/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin, Photodiagn. Photodyn. Ther., 2013, 104, 470\u2013483.","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"7","key":"1506011_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1055\/s-2002-32902","volume":"68","author":"P Solar","year":"2002","unstructured":"P. Solar, I. Cavarga, J. Hofmanova, M. Cekanova-Figurova, P. Miskovsky, P. Brezani, G. Hrckova, A. Kozubik and P. Fedorocko, Effect of acetazolamide on hypericin photocytotoxicity, Planta Med., 2002, 687, 658\u2013660.","journal-title":"Planta Med."},{"issue":"10","key":"1506011_CR26","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.1158\/0008-5472.CAN-06-4785","volume":"67","author":"A Ferrario","year":"2007","unstructured":"A. Ferrario, N. Rucker, S. Wong, M. Luna and C. J. Gomer, Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response, Cancer Res., 2007, 6710, 4989\u20134995.","journal-title":"Cancer Res."},{"key":"1506011_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.freeradbiomed.2012.12.005","volume":"57","author":"R Bhowmick","year":"2013","unstructured":"R. Bhowmick and A. W. Girotti, Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress, Free Radical Biol. Med., 2013, 57, 39\u201348.","journal-title":"Free Radical Biol. Med."},{"issue":"3","key":"1506011_CR28","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jphotobiol.2011.05.001","volume":"104","author":"I S Cogno","year":"2011","unstructured":"I. S. Cogno, N. B. Vittar, M. J. Lamberti and V. A. Rivarola, Optimization of photodynamic therapy response by survivin gene knockdown in human metastatic breast cancer T47D cells, J. Photochem. Photobiol., B, 2011, 1043, 434\u2013443.","journal-title":"J. Photochem. Photobiol., B"},{"issue":"12","key":"1506011_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrm3474","volume":"13","author":"M Carmena","year":"2012","unstructured":"M. Carmena, M. Wheelock, H. Funabiki and W. C. Earnshaw, The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis, Nat. Rev. Mol. Cell Biol., 2012, 1312, 789\u2013803.","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"1506011_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/jor.22819","volume":"33","author":"E V Froehlich","year":"2015","unstructured":"E. V. Froehlich, B. Rinner, A. J. Deutsch, K. Meditz, H. Knausz, K. Troppan, S. Scheipl, C. Wibmer, A. Leithner, B. Liegl and B. Lohberger, Examination of survivin expression in 50 chordoma specimens\u2013A histological and in vitro study, J. Orthop. Res., 2015, 335, 771\u2013778.","journal-title":"J. Orthop. Res."},{"issue":"3","key":"1506011_CR31","first-page":"621","volume":"27","author":"D Dai","year":"2012","unstructured":"D. Dai, Y. Liang, Z. Xie, J. Fu, Y. Zhang and Z. Zhang, Survivin deficiency induces apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells, Oncol. Rep., 2012, 273, 621\u2013627.","journal-title":"Oncol. Rep."},{"issue":"2","key":"1506011_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.canlet.2007.12.004","volume":"262","author":"T Wang","year":"2008","unstructured":"T. Wang, J. Wei, X. Qian, Y. Ding, L. Yu and B. Liu, Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells, Cancer Lett., 2008, 2622, 214\u2013222.","journal-title":"Cancer Lett."},{"issue":"23","key":"1506011_CR33","first-page":"8241","volume":"63","author":"M Blank","year":"2003","unstructured":"M. Blank, M. Mandel, Y. Keisari, D. Meruelo and G. Lavie, Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin, Cancer Res., 2003, 6323, 8241\u20138247.","journal-title":"Cancer Res."},{"issue":"40","key":"1506011_CR34","doi-asserted-by":"publisher","first-page":"37718","DOI":"10.1074\/jbc.M204348200","volume":"277","author":"A Vantieghem","year":"2002","unstructured":"A. Vantieghem, Y. Xu, Z. Assefa, J. Piette, J. R. Vandenheede, W. Merlevede, P. A. De Witte and P. Agostinis, Phosphorylation of Bcl-2 in G2\/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis, J. Biol. Chem., 2002, 27740, 37718\u201337731.","journal-title":"J. Biol. Chem."},{"issue":"3","key":"1506011_CR35","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1124\/jpet.110.168856","volume":"334","author":"X Wang","year":"2010","unstructured":"X. Wang, Y. Guo, S. Yang, C. Wang, X. Fu, J. Wang, Y. Mao, J. Zhang and Y. Li, Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells, J. Pharmacol. Exp. Ther., 2010, 3343, 847\u2013853.","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"1506011_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2174\/092986712799034842","volume":"19","author":"B Krammer","year":"2012","unstructured":"B. Krammer and T. Verwanger, Molecular response to hypericin-induced photodamage, Curr. Med. Chem., 2012, 196, 793\u2013798.","journal-title":"Curr. Med. Chem."},{"issue":"40","key":"1506011_CR37","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1038\/onc.2014.458","volume":"34","author":"S Fulda","year":"2015","unstructured":"S. Fulda and D. Kogel, Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy, Oncogene, 2015, 3440, 5105\u20135113.","journal-title":"Oncogene"},{"key":"1506011_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1476-4598-10-35","volume":"10","author":"R J Kelly","year":"2011","unstructured":"R. J. Kelly, A. Lopez-Chavez, D. Citrin, J. E. Janik and J. C. Morris, Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin, Mol. Cancer, 2011, 10, 35.","journal-title":"Mol. Cancer"},{"issue":"1","key":"1506011_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3892\/or.2015.3947","volume":"34","author":"Y Yu","year":"2015","unstructured":"Y. Yu, X. Zhao, Y. Zhang, Y. Kang, J. Wang and Y. Liu, Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma, Oncol. Rep., 2015, 341, 407\u2013414.","journal-title":"Oncol. Rep."},{"issue":"1","key":"1506011_CR40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ygyno.2013.11.013","volume":"132","author":"R Mir","year":"2014","unstructured":"R. Mir, E. Stanzani, F. Martinez-Soler, A. Villanueva, A. Vidal, E. Condom, J. Ponce, J. Gil, A. Tortosa, P. Gimenez-Bonafe, YM155 sensitizes ovarian cancer cells to cisplatin inducing apoptosis and tumor regression, Gynecol. Oncol., 2014, 1321, 211\u2013220.","journal-title":"Gynecol. Oncol."},{"issue":"21","key":"1506011_CR41","first-page":"2909","volume":"17","author":"H Liang","year":"2013","unstructured":"H. Liang, L. Zhang, R. Xu and X. L. Ju, Silencing of survivin using YM155 induces apoptosis and chemosensitization in neuroblastomas cells, Rev. Eur. Sci. Med. Pharmacol., 2013, 1721, 2909\u20132915.","journal-title":"Rev. Eur. Sci. Med. Pharmacol."}],"container-title":["Photochemical & Photobiological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1039\/c5pp00438a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1039\/c5pp00438a\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/pubs.rsc.org\/en\/content\/articlepdf\/2016\/PP\/C5PP00438A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1039\/c5pp00438a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T15:04:38Z","timestamp":1667401478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1039\/c5pp00438a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["1506011"],"URL":"https:\/\/doi.org\/10.1039\/c5pp00438a","relation":{},"ISSN":["1474-905X","1474-9092"],"issn-type":[{"value":"1474-905X","type":"print"},{"value":"1474-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"26 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}